In a randomized, double-blind, placebo-controlled study, individuals were given 125 mg of Pycnogenol or a placebo daily
Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinsons disease receiving r-metHuGDNF via continuous intraputaminal infusion
The initial mass loss observed below 120 C was attributed to the removal of physically adsorbed and bound water
Long-term outcomes following CAR T cell therapy: what we know so far
AFWERXs SBIR program is among the most innovative in defense acquisition because it is tailored to help companies new to defense orient to the defense market, prepare a phase II proposal, and successful participating companies are eligible for additional support
At Lone Star Center for Health and Wellness, our team recognizes that not all vitamin B12 is created equal